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Abstract
Male odors can influence a female’s reproductive physiology. In the mouse, the odor of male urine results in an early onset
of female puberty. Several volatile and protein pheromones have previously been reported to each account for this
bioactivity. Here we bioassay inbred BALB/cJ females to study pheromone-accelerated uterine growth, a developmental
hallmark of puberty. We evaluate the response of wild-type and mutant mice lacking a specialized sensory transduction
channel, TrpC2, and find TrpC2 function to be necessary for pheromone-mediated uterine growth. We analyze the relative
effectiveness of pheromones previously identified to accelerate puberty through direct bioassay and find none to
significantly accelerate uterine growth in BALB/cJ females. Complementary to this analysis, we have devised a strategy of
partial purification of the uterine growth bioactivity from male urine and applied it to purify bioactivity from three different
laboratory strains. The biochemical characteristics of the active fraction of all three strains are inconsistent with that of
previously known pheromones. When directly analyzed, we are unable to detect previously known pheromones in urine
fractions that generate uterine growth. Our analysis indicates that pheromones emitted by males to advance female
puberty remain to be identified.
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Introduction
Specialized odor cues, such as pheromones, influence the
display of stereotyped behaviors [1]. Pheromones have been
characterized to generate either signaling activity, which upon
detection rapidly initiates behavior such as aggression or fear [2,3],
or priming activity, which usually alters hormone levels and
influences behavior over several days [4,5]. Primer pheromones
emitted by males induce female estrus [6]. Pheromone-mediated
estrus induction, also known as the Whitten effect in rodents,
advances both male and female reproductive fitness. It has been
described in many mammalian species, including rodents, sheep,
goats, cattle, swine [1,7], and has been proposed to occur in
humans [8]. Pheromones have also been implicated in promoting
male acceleration of female puberty, the Vandenbergh effect [9],
which is characterized by the development of reproductive organs,
a hallmark of which is uterine growth, and an increase in hormone
signaling [5].
The identities of the chemosensory ligands that induce estrus in
most species are largely unknown. In the mouse, sexual
maturation of young females is promoted by odors excreted in
male mouse urine [9]. Characterization of these odors has been
initiated through three independent approaches. First, direct
evaluation of male urinary fractions that generate the Vanden-
bergh effect, indicated by first estrus or uterine growth, have found
that the pheromone is hydrophilic [10,11], relatively small [12,13],
and nonvolatile [13–15]. It had been observed that circulating
male androgens are necessary to produce puberty-accelerating
urine [9,11,16]. Therefore in a second approach, others applied
subtractive gas chromatography-mass spectrometry (GCMS)
methods to screen for compounds enriched in urine from intact
males compared to castrated male urine, an androgen-negative
control [17–19]. This approach identified several compounds
including isoamylamine (IAA), isobutylamine (IBA), 3,4-dehydro-
exo-brevicomin (DHB), 2-sec-butyl-4,5-dihydrothiazole (SBT), 6-
hydroxy-6-methyl-3-heptanone (HMH), and a/b-farnesene
[17,19]. These ligands do not have the same physical character-
istics as the puberty-accelerating urine fractions identified in the
first approach. However, when subsequently tested for bioactivity,
several of these volatile androgen-regulated compounds were
reported as primer pheromones that accelerate female puberty
[17,18] and among these, some were additionally reported to have
dual functions as signaling pheromones [20–22]. Subsequently,
several of these molecules have been shown to be ligands that
directly activate vomeronasal (VNO) and other chemosensory
neurons [23,24], which are known to detect some pheromone
ligands [1]. In a third approach, two androgen regulated non-
volatile compounds have been reported to accelerate puberty:
major urinary proteins (Mups) [25] and a hypothetical Mup
peptide formed from the six N-terminal Mup residues (EEARSM)
[10,26]. In native urine, Mups are known to bind and reduce the
volatility of most of the androgen-regulated small molecule ligands
[27,28]. The biological significance of most ligands that activate
mouse VNO neurons has not been elucidated [29,30] therefore, it
is striking that each of these approaches identified different
compounds that similarly function to advance the onset of female
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16660puberty. Whether each of these ligands is equally effective to
accelerate puberty or whether they are naturally synergistic has
not been investigated.
Here we have applied an assay for pheromone-mediated uterine
development to inbred BALB/cJ mice [9–18]. We evaluated the
response of wild-type and TrpC2 mutant mice, which lack the
primary sensory channel of the vomeronasal organ (VNO) [31,32],
and found the mutant animals to be unresponsive to puberty
accelerating pheromones. We exposed BALB/cJ females to
previously identified puberty accelerating pheromones and found
all to be inactive in our assay. Finally, we fractionated urine to
characterize general properties of the pheromone. We find male
urine produced from genetically distinct mouse strains to each
have pheromone activity in similarly prepared fractions and
previously identified pheromones to be undetectable from the
active fraction in all three strains. Our experiments suggest that
pheromones that increase uterine mass, and thereby accelerate
puberty, remain to be identified.
Results
Pheromone-mediated uterine weight increase in BALB/cJ
females
To investigate the olfactory ligands that result in puberty
acceleration, we utilized an in vivo bioassay with inbred, BALB/cJ,
female mice. After weaning, chemosensory stimuli were directly
applied to the nares of female juveniles twice daily for six days (see
Materials and Methods for details). On day seven, both uterine
and body masses were measured. Consistent with the Vanden-
bergh effect [5,9], male urine promotes a significant development
of the uterus of BALB/cJ females as indicated by increased wet
uterine mass (Fig. 1A, C) without effect on total body mass
(Fig. 1B). C57BL/6J females failed to demonstrate uterine weight
increase under similar conditions (data not shown), a result which
underscores the known influence of genetic background
on pheromone-mediated behaviors [33]. The puberty accelera-
tion bioassay in the BALB/cJ strain provides a screen by
which putative pheromones and chemosensory neurons may be
investigated.
The molecular profile of the puberty accelerating chemosensory
neurons has not been identified, but surgical ablations of either the
VNO or the main olfactory system have indicated that puberty
accelerating pheromones are detected by unknown neurons within
the VNO [34–36]. The function of TrpC2, the primary sensory
channel of VNO neurons, is required to detect and respond to
some pheromones [32,37–39]. In order to analyze the role of
TrpC2 function in pheromone-mediated uterine weight gain, we
fully introduced the TrpC2 mutation [32] into the BALB/cJ
genetic background (see Materials and Methods). Littermate
progeny of TrpC2+/- (BALB/cJ) breeders were exposed to urine
and their uterine weight was assayed blind of genotype (Fig. 1D,
E). Subsequent genotyping revealed that TrpC2 null congenic
females failed to increase uterine mass in response to the
pheromone(s) in male urine (Fig. 1D, E), indicating that TrpC2
function is necessary to detect and respond to pheromones that
increase uterine weight.
Evaluation of pheromones previously identified to
accelerate puberty
We next evaluated the bioactivity of pheromones that were
previously reported to accelerate puberty: IAA, IBA, HMH, SBT,
b-farnesene, EEARSM, and Mups. We first directly investigated
the activity of the Mups. Male urine was ultrafiltrated to size
fractionate the larger Mup proteins from small molecules. SDS-
Figure 1. Male urinary pheromones alter female reproductive physiology. (A) Six-day exposure to male urine increases uterine mass, an
indirect assay for puberty acceleration. Left; dissected uterus from a PBS-exposed female, right; dissected uterus from a female exposed to male urine.
Scale bar, 1 cm. (B) Urine pheromones do not increase total body mass (t-test, p=0.441). n=13 per group. (C) Exposure to male urine results in an
increase in uterine mass (t-test). n=13 per group. (D) Urine pheromones and TrpC2 genotype have no significant effect on body mass (p=.132).
n=9–16 per group. (E) Exposure of TrpC2-/- females to male urine does not result in an increase in uterine mass (Tukey’s HSD). n=9–16 per group.
PBS; phosphate buffered saline, U; male urine. (see Methods for explanation of box and whisker plot representation). *p,0.05, ***p,0.001.
doi:10.1371/journal.pone.0016660.g001
Uterine Growth Pheromones
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16660PAGE analysis revealed that the high molecular weight (HMW)
retentate contained detectable proteins (Fig. 2A), which were the
expected size of Mups [40]. When analyzed in the bioassay, we
found the low molecular weight (LMW) filtrate and whole urine to
each increase uterine mass, while the Mup-containing HMW
retentate showed no significant bioactivity (Fig. 2B). This finding is
consistent with a previous study evaluating the puberty acceler-
ating effect of a recombinant Mup [18]. The absence of protein
from LMW fractions and the lack of bioactivity in the HMW
fraction argue against the role of Mups as pheromones that
accelerate reproductive organ development. All of the remaining
previously identified pheromones are smaller than 3000Da and are
expected to be present in LMW urinary fractions.
We used three separate approaches to directly evaluate the
extent to which other previously identified puberty inducing
pheromones increase uterine mass. In all of our experiments, we
analyzed the ligands using the concentrations and vehicles
previously reported for bioactivity [10,17,18,41]. First, we assessed
Figure 2. Analysis of pheromones previously identified to accelerate puberty. (A) SDS-PAGE of fractionation of urine by molecular mass;
high molecular weight retentate (HMW .3 kDa,), low molecular weight (LMW,3 kDa). kDa size marker on left. (B) Exposure to LMW urine fractions
increases uterine mass (Dunnett’s). (End body masses are not significantly different, p=0.237). Averages of body mass (g): PBS, 16.78; HMW, 16.46;
LMW, 16.64; urine, 16.8. n=10–19 per group. (C) b-farnesene (250ppm) and isoamyl- and isobutylamine (50 mM each) presented in water do not
increase uterine weight (Tukey’s HSD). (End body masses are not significantly different, p=0.348). Averages of body mass (g): water, 17.43; b-
farnesene, 17.71; iso-amines, 17.41; urine, 18.03. n=7–8 per group. (D) SBT (2.6 ppm), HMH (2000 ppm), and EEARSM (0.5 mg/ml) presented in water
or PBS do not significantly increase uterine mass (Tukey’s HSD). (End body masses are not significantly different, p=0.808). Averages of body mass
(g): water, 17.25; SBT, 17.56; HMH, 17.26; EEARSM, 17.24; urine, 17.62. n=10 per group. (E) A blend of known pheromones (b-farnesene, IAA, IBA,
HMH, SBT, and EEARSM) in PBS does not significantly increase uterine mass (Tukey’s HSD). (End body masses are not significantly different, p=0.20).
Averages of body mass (g): PBS, 16.79; pheromones, 17.05; urine, 17.36. n=13 per group. (F) Neither water nor a blend of known pheromones (b-
farnesene, HMH, SBT, and EEARSM) added to urine from castrated males (+ castrated MU) generates an increase in uterine mass (Tukey’s HSD). (End
body masses are not significantly different, p=0.286). Averages of body mass (g): PBS, 16.81; castrate MU, 16.97; blend castrate MU, 17.03; urine,
17.45. n=8–10 per group. *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0016660.g002
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described. Exposure of BALB/cJ females to commercially
available synthetic pheromones, b-farnesene, and blended IAA
and IBA, failed to significantly increase uterine mass (Fig. 2C).
Custom synthesized pheromones, HMH, SBT, and hexapeptide
EEARSM also lacked the ability to significantly increase uterine
weight when individually tested (Fig. 2D).
Second, while these pheromones were not reported to function
as an obligate blend, some invertebrates respond to blends of
structurally related sex pheromones with potentiated bioactivity
[42,43]. We therefore evaluated whether the bioactivity of these
previously identified pheromones was more apparent as a blend.
Mice were exposed to a mixture of IAA, IBA, b-farnesene, SBT,
HMH and EEARSM. This complex blend of pheromones failed
to increase uterine mass (Fig. 2E). Lastly, SBT has been reported
to additionally act as a signaling pheromone, but only when added
to urine from castrated males (which alone does not generate
bioactivity) [22]. Therefore, we aimed to determine if the
previously identified pheromones accelerate puberty in conjunc-
tion with other unidentified male odors that may be present in
castrated urine. In the first two approaches we observed aversion
to IAA and IBA and considering the toxicity of inhaled aliphatic
amines in mice [44], these ligands were excluded from this final
direct assessment. As previously described [22], we added b-
farnesene, SBT, HMH, and EEARSM into urine from castrated
males, providing urinary context. However, we found both the
urine from castrated males alone and castrated urine supplement-
ed with the blend of pheromones similarly unable to significantly
increase uterine weight (Fig. 2F). In total, all three methods of
direct analyses of previously identified pheromones did not
accelerate BALB/cJ reproductive organ development in our
bioassay.
Biochemical characteristics of pheromones that increase
uterine mass
We next evaluated the biochemical characteristics of the activity
that accelerates pubertal uterine mass increase in the urine LMW
fraction. First, we determined the extent to which pheromones
that increase uterine mass are volatile. We lyophilized LMW
urine, which is devoid of volatile-stabilizing Mups [18,27] and
found it to retain significant bioactivity (Fig. 3A), confirming that
the pheromone is not highly volatile [13,14]. We next fractionated
LMW urine by solvent extraction and both the organic and
aqueous phases were screened for the ability to increase uterine
mass (Fig. 3B). Hydrophobic molecules extracted into the organic
phase failed to demonstrate any bioactivity while the aqueous
phase significantly accelerated uterine growth (Fig. 3B), confirming
that the pheromone is preferentially aqueous [10,11].
To further identify basic biochemical properties of the
pheromone, we continued to use the bioassay to track the activity
through several purification steps and collected the pheromone by
solvent precipitation to generate a partially purified pheromone
‘‘pellet’’ fraction (see Materials and Methods for details). Attempts
to further isolate the pheromone with routine adsorption to C18
reverse-phase solid phase extraction (RP-SPE) columns were
unsuccessful. We found the hydrophilic flow-through which was
collected as a batch using C18-high pressure liquid chromatog-
raphy (HPLC) demonstrated significant bioactivity in contrast to
hydrophobic compounds that eluted under higher solvent strength
(data not shown). We therefore considered that the pheromone
might be adsorbed to hydrophilic matrices using aqueous normal
phase-SPE (NP-SPE) and evaluated a small panel of normal phase
matrices for eluted bioactivity. We found further fractionation of
the pheromone ‘‘pellet’’ over an amino column under aqueous
normal phase conditions to recover the puberty acceleration
bioactivity (Fig. 3C). The ability to isolate the pheromone by NP-
SPE methods and the inability of the pheromone to bind
hydrophobic C18 columns indicate that the pheromone is
hydrophilic, consistent with our results using solvent extraction
(Fig. 3B). Importantly, we find both the NP-SPE fraction and total
urine to be similarly effective in promoting uterine weight gain
(Fig. 3D). Collectively, this analysis indicates that the biochemical
characteristics of ligands in the bioactive fraction (Fig. 3) are
inconsistent with those of previously identified pheromones (see
Table 1).
The bioactive urinary fraction is similarly extracted from
three mouse strains
The constituents of adult male mouse urine vary significantly
between strains [45–48] and result in strain-specific differences of
male urine to stimulate chemosensory neurons [49,50], attract
females [51–53] and trigger ovulation [54]. To evaluate the extent
to which pheromones which increase uterine mass are produced
by different strains of laboratory mice, we assayed male urine from
BALB/cJ, C57BL/6J, and CD-1 lineages. We found total urine
from all three strains of mice to each significantly increase uterine
mass (Fig. 4A). We next similarly prepared NP-SPE fractions from
these individual strains and found them each to contain significant
bioactivity (Fig. 4B). This suggests that pheromones which
function to accelerate pubertal uterine growth emitted from
BALB/cJ, C57BL/6J, and CD-1 strains share similar biochemical
characteristics.
A novel pheromone in the bioactive urinary fraction
To further evaluate the nature of our partially purified
bioactivity we directly analyzed urine for the presence of
previously known pheromones. The GCMS fragmentation
patterns of SBT, HMH, and b–farnesene standards (Fig. 4C) as
well as published fragmentation patterns of DHB [55] and a-
farnesene were acquired prior to sample analyses. IAA, IBA and
EEARSM standards were detected by liquid chromatography
(LCMS) (Fig. 4E, F). Using these compound standards and
published fragmentation data we analyzed total urine of BALB/cJ,
C57BL/6J and CD-1 strains by LC- and GCMS for these
previously identified pheromones. We found SBT, IAA, and DHB
were readily detectable in the organic extracts of BALB/cJ,
C57BL/6J and CD-1 male urine and HMH was detected in
samples of BALB/cJ and C57BL/6J male urine (Fig. 4D, E).
While b–farnesene, IBA, and EEARSM standards were detected
by our methods we were unable to find them present in male
mouse urine from any of these strains (Fig. 4C, D, E, F).
Importantly, when we performed the same analysis on the
bioactive NP-SPE fraction from each strain we were unable to
detect any of these previously known pheromones (Fig. 4C, D, E,
F). These results suggest that the pheromone enriched in the NP-
SPE fraction of urine from several laboratory strains is likely to be
novel.
Discussion
Though pheromone-mediated estrus acceleration is a wide-
spread mammalian phenomenon, the neural mechanism by which
priming pheromones affect reproductive physiology and behavior
is largely unknown. In order to study the chemosensory
modulation of reproductive organ development, we applied a
bioassay to investigate pheromone-mediated acceleration of
uterine mass to BALB/cJ inbred females. We used this assay to
assess the functional relevance of TrpC2 and screen for
Uterine Growth Pheromones
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function of TrpC2 to be required for the female pubertal response
to male urine providing first molecular characterization of the
sensory neurons that mediate this pheromone response. Our
current experiments cannot identify whether the salient population
of TrpC2 neurons are located in the main olfactory epithelium or
Table 1. Summary of biochemical properties of stimuli.
Stimulus MUP EEARSM IAA IBA farnesene SBT HMH DHB NP-SPE
Reference [10] [10] [17] [17] [18] [18] [18] [18] This study
,3000Da - 3 333 33 3 3
Involatile 33 --- -- - 3
Aqueous 33 --- -- - 3
Uterine hypertrophy - - - - - - - ND 3
Aqueous, activity recovered by organic extraction. Uterine hypertrophy, ligand accelerated uterine hypertrophy. ND, not determined.
doi:10.1371/journal.pone.0016660.t001
Figure 3. Fractionated bioactivity has biophysical characteristics that are inconsistent with known pheromones. (A) Lyophilization of
LMW urine, to remove volatile urinary constituents, retains the bioactivity of a fresh LMW fraction (Dunnett’s). (End body masses are not significantly
different, p=0.296). Averages of body mass (g): PBS, 17.90; lyoph LMW, 17.83; LMW, 17.50. n=21–23 per group. (B) Pheromones that increase uterine
mass are not extracted into chloroform (ORG), they are retained in the aqueous phase (AQ) (Tukey’s HSD). (End body masses are not significantly
different, p=0.313). Averages of body mass (g): PBS, 17.41; ORG, 17.29; AQ, 16.98; LMW, 17.29. n=20–35 per group. (C) Analysis of uterine weight
folowing purification of the partially purified ‘‘pellet’’ by an NH2 column using aqueous normal phase-solid phase chromotography (NP-SPE)
(Dunnett’s). (End body masses are not significantly different, p=0.786). Averages of body mass (g): PBS, 17.46; NP-SPE, 17.58; pellet, 17.62. n=24–28
per group. (D) Comparison of retained bioactivity in NP-PSE fraction to total urine (Tukey’s HSD; indicated p values relative to PBS). (End body masses
are not significantly different. P=0.783). Averages of body mass (g): PBS, 17.52; NP-SPE, 17.41; urine, 17.50. n=50–56 per group. PBS; phosphate
buffered saline, LMW; low molecular weight urine size fraction. n.s., not significant, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0016660.g003
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previously identified role of the VNO in pubertal acceleration [34–
36] and the function of TrpC2 in signaling to pheromone-
responsive neural circuits [32,38,39]. MHC peptides emitted by
males have been reported to block the activity of estrus-inducing
male pheromones thereby ensuring pregnancy in recently mated
BALB/cJ females in the presence of the stud male (termed the
Bruce effect) [45,56]. Interestingly, both behavioral and electro-
physiological studies find that the response to MHC ligands is
similar in wild-type and TrpC2-/- mutant animals [57] indicating
Figure 4. Known pheromones are not present in the bioactive NP-SPE fraction from three different strains. (A) Male urine of BALB/cJ,
C57BL/6J, and CD-1 each diluted 1:3 in PBS promotes uterine weight increase in female mice (Dunnett’s). (End body masses are not significantly
different, p=0.839). Averages of body mass (g): PBS, 17.29; BALB/cJ, 17.47; C57, 17.40; CD-1, 17.26. n=27 per group. (B) Females exposed to the NP-
SPE amino-column elutions from three different mouse strains display uterine weight gain (Dunnett’s). (End body masses are not significantly
different p=0.662.) Averages of body mass (g): PBS, 17.41; BALB/cJ, 17.40, C57, 17.39; CD-1, 17.11.n=14–15 per group. (C) GCMS chromotograph of
pheromone standards HMH (1), SBT (3), and b-farnesene (4) as indicated. Fragmentation patterns of standards were used for analysis. (D) GCMS total
ion chromatographs for known pheromones from total urine (black trace) and bioactive NP-SPE fractions (red trace) from BALB/c, C57BL/6J, and CD-1
male donors. Detection of HMH (1), DHB (2), and SBT (3) are indicated. No extractable compounds, including these known pheromones, were
detectable in NP-SPE samples. The NP-SPE red trace is offset below the urine trace to visualize the lack of detectable peaks, the y-axis is otherwise
identical. (E) LCMS/MS analysis of bioactive NP-SPE samples from BALB/c, C57BL/6J, and CD-1 male donors does not detect the presence of IAA and
IBA using fragmentation patterns obtained from standards (top) as indicated. Arrow indicates the exact mass of the parent ion. (F) Analysis of
EEARSM peptide using the mass of the transition state during dissociation of the standard (top). EEARSM was not detectable in any of the NP-SPE
samples from any strain. In panels E-F the y-axis are identical between standards and NP-SPE samples. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0016660.g004
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function. Consideration of these studies with our current findings
suggests that the novel pheromone signaling that initiates first
estrus during development and the MHC peptide signaling that
inhibits estrus to promote pregnancy in adults utilize different
signaling mechanisms.
Although we were unable to reproduce the bioactivity of
previously known pheromones, the chemical properties of the
bioactive urine fraction in our assay are in agreement with earlier
studies which determined that the pheromone is relatively small,
hydrophilic, and nonvolatile [12,13,15]. These properties are
inconsistent with those of any previously known pheromones that
were attributed with puberty accelerating activity (see Table 1).
We were unable to obtain the material to use our BALB/cJ
bioassay to directly evaluate the effects of a-farnesene or DHB,
which have also been reported to advance puberty [18]. However,
we were able to screen our partially purified ‘‘pellet’’ for evidence
of these compounds and found no signals that matched published
fragmentation data for either a-farnesene or DHB (Fig. 4C, D)
[19,41]. It should be noted that the discrepancies we observed in
bioactivity of previously known pheromones may be due to
differences in assay conditions, diet, housing conditions, littermate
sex ratios, or the genomic variability between the outbred or
hybrid experimental animals used in earlier studies and our use of
the inbred, BALB/cJ, strain [10,17,18,58–61]. Further purifica-
tion of ligands that increase uterine mass will enable the
identification of the detecting sensory receptors in BALB/cJ and
provide the means to investigate such differences.
Our ability to purify the bioactivity using the same fractionation
method (NP-SPE) from BALB/cJ, C57BL/6J, and CD-1 mice
suggests that our novel bioactivity is either commonly excreted or
is generated by structurally related pheromones. The hypothesis
that three different strains may be producing a similar pheromone
is not typical among known mouse pheromones. For example
pheromones emitted from males including the female attractant,
Darcin-Mup [53], the female arousing pheromone, ESP1 [38],
and the pregnancy blocking MHC peptides [45] vary in expression
between black (C57BL/6J) and albino (BALB/cJ) mouse strains.
This expression difference of emitted ligands results in strain-
specific variation of the male’s ability to elicit pheromone
mediated behaviors in females. Such mouse pheromones are
genetically encoded and regulated by transcription. Conserved
production of a pheromone with similar biophysical characteristics
between three different strains may indicate that the pheromone is
a metabolite produced by the common constraints of rodent
physiology. The identification of the pheromone will provide
insight into the evolution of priming pheromone production.
In summary, we have applied a bioassay for pheromone-
mediated pubertal development in an inbred strain to characterize
and identify puberty priming pheromones. We find that
pheromone-mediated reproductive organ development is depen-
dent upon TrpC2 expression and is not mediated by previously
known pheromones. Future studies are required to identify the
novel pheromone(s) within the NP-SPE fraction that advances the
sexual maturation of female mice.
Materials and Methods
Animals
All procedures were approved by the Institutional Animal Care
and Use Committee (IACUC) approval number 06-0298. BALB/
cJ female mice were obtained from the TSRI breeding colony at
20–22 days of age and weighed. TrpC2 mutant animals [32] were
backcrossed with BALB/cJ animals and the genotype was
analyzed with a panel of 300 single-nucleotide polymorphisms
(SNPs). This was repeated to generateTrpC2 null animals with a
99% BALB/cJ genetic background; a minimum of 3 additional
backcrosses were subsequently performed. All TrpC2 mutant
animals used in this study were of the BALB/cJ background. Male
urine donors (CD-1, BALB/cJ, and C57BL/6J) were housed in
groups of 3-5, including at least one stud male. Fresh urine from
males 2–6 months of age was collected in metabolic cages and
clarified by centrifugation prior to use. All male urine was from the
CD-1 strain unless noted otherwise. Castrated male urine was
collected from adult CD-1 males that were castrated at 3–4 weeks
of age. Urine was used within 1–48 hrs of collection, kept at 4uC
when stored overnight and warmed to ambient temperature prior
to use. Upon weaning, female mice were individually caged in a
room without males. All mice were maintained in 7.561165’’
polysulfone cages, ventilated at 60 ACH with a 12:12 h light/dark
cycle (on at 0700 h) in a temperature-controlled room and kept on
the Harlan Teklad LM-455 diet.
Pubertal acceleration bioassay
Prior to each experiment, mice were individually housed.
Animals were assigned to weight-matched group (one-way
ANOVA, p.0.9). Beginning at 22–24 days of age, BALB/cJ
females that weighed 12.0–15.0 g body weight, were treated twice
daily with variable chemosensory stimuli painted on the external
nares with a synthetic paintbrush dipped into a tube containing
0.5 ml of stimulus (except for IAA and IBA, detailed below). Male
urine was collected from mice of the CD-1 strain unless otherwise
indicated. To apply the stimulus, mice were restrained by hand in
a supine position and slowly stroked with the stimulus until it
bubbled at the nostrils, stroked again, and replaced in the cage.
On average, cages were disturbed for 13 seconds and mice were
handled for 6 seconds, during which ,15 ml were applied, for
each of 12 total exposures. Females were observed to be
behaviorally aversive to direct application of 50 mM IAA or
IBA (KAF unpublished observations) therefore; these stimuli were
applied to a 0.75cm cotton ball and left in the cage as previously
described [17]. On day seven, at 28–30 days of age, mice were
euthanized and body weight was recorded. Animals were
approximately 17 g at the end of each assay. Each uterus was
rapidly dissected, removed of fat, and weighed. The progeny of
TrpC2
+/- breeders were assayed blind of genotype and tail
samples were collected for genotyping.
Genotyping
Mice were genotyped by multiplex PCR. To identify the wild-
type TrpC2 gene, we used two primers to amplify the pore region
of the ion channel: sense, 59-GGCCATCTTCTTTTACA-
TATGC, and antisense 59-GAAACAAGGGAATGCAGG. The
deleted gene was replaced with a PGK-neo cassette in the mutant
mice [32] which was amplified using the following primers: 59-
CCTGATCGACAAGACCGGCTTC and 59-GTGTTCCGGC-
TGTCAGCGCA.
Evaluation of putative pheromones
To separate HMW from LMW urinary constituents, fresh urine
was passed through Amicon Ultra-4 centrifugal filters with a cutoff
of 3 kDa. Following the transfer of the LMW filtrate, the retentate
was washed 2–3 times with 3–4 ml PBS and raised to original
volume. Putative pheromones were dissolved as previously
described. IAA and IBA (Sigma) were suspended in water at
0.05M [17]. b-farnesene (Bedoukian) was suspended in water at
250ppm (,1.2 mM) [18,41]. Racemic SBT [2] was suspended in
water at 2.6 ppm (,18 mM) [18]. HMH (a generous gift from
Uterine Growth Pheromones
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[18]. The NH2-EEARSM hexapeptide (TSRI Peptide Synthesis
Core Facility, 95% purity) was dissolved in phosphate buffered
saline (PBS) at 0.5 mg/ml (,690 mM) [10]. Pheromones were
blended at these concentrations, except for isoamyl- and
isobutylamine, which were provided on a cottonball inside the
cage as previously described [17].
SDS-PAGE
10 ml crude urine, HMW or LMW urinary fractions were
desalted with G-50 spin columns (GE-Amersham) and loaded
alongside standard ladder on a 10% acrylamide gel. Following
electrophoresis, the gel was stained with Coomassie blue.
Biochemical characterizations and fractionation
procedures
To remove urinary volatiles, LMW urine was flash-frozen with
liquid nitrogen, lyophilized under vacuum pressure for 24–48 hrs
and stored at 4uC until use. Organic extraction of LMW urine was
conducted with rigorous shaking in a glass separatory funnel using
two volumes chloroform and one volume methanol. Each phase
was collected and evaporated under vacuum pressure until
chloroform was removed. In order to isolate the pheromone for
column chromatography, LMW urine was precipitated with four
volumes methanol on ice for 30 min. Following centrifugation,
both fractions were dried, resuspended to original volumes, and
assayed for the ability to increase uterine weight. While the
precipitate had no bioactivity, the methanol solutes significantly
accelerated uterine hypertrophy (p,0.001, Tukey’s HSD).
Thereafter, the precipitant was discarded and the supernatant
was further fractionated with five volumes ice cold acetone on ice
for 1 hr. Following centrifugation, each fraction was dried,
resuspended to original volume, and tested in the bioassay. We
found the supernatant to be inactive and acetone precipitate to
significantly accelerate uterine hypertrophy (p,0.01, Tukey’s
HSD). Thereafter, this bioactive ‘‘pellet’’ was dried and stored at
280uC for up to two months. To further isolate the pheromone
with NP-SPE, approximately 20 mg of material (obtained from
1 ml crude urine) were suspended in 250 ml 50% acetonitrile and
applied to a 500 mg NH2 column (Supelco), equilibrated with
acetonitrile. Several experiments were conducted to determine
wash conditions that enabled us to retrieve bioactivity from the
column (unpublished observations) and we found 10–15 ml 80%
acetonitrile, 10% methanol to be optimal. The wash was
discarded. The NP-SPE fraction was eluted with 1.0 ml water
and stored at 4u up to two days. Samples were dried in a speed
vacuum. All concentrated samples were reconstituted to original
volume with water or PBS prior to use.
Mass spectrometry
For GCMS, 0.5 ml chloroform was added to 0.5 ml fresh urine
or the NP-SPE elution in a glass vial, vortexed, and stored overnight
at 220uC. The lower organic phase was removed from thawed
samples and stored at 220uC until analysis that day. 1 ml samples
were analyzed by splitless injection onto a 30 m6250 um ID
HP5ms column with He2 carrier gas at a 1.2 ml?min
21 flow-rate.
The temperature program began at 50uC, held for 5 minutes,
ramped to 300uCa t1 0 uC?min
21 and held for 5 minutes. MS scans
were from m/z 50–700 with a 5-minute solvent delay. For LCMS-
MS, NP-SPE samples and pheromone standards were analyzed by
quadrupole time-of-flight (QTOF) and a triple quadrupole mass
spectrometer by single multiple reaction monitoring (SMRM). For
QTOF analysis, 5 ml( ,5%) of samples were resolved online with a
Sequant ZIC-HILIC column, 2.1 mm6150 mm, using a 50 mM
NH4OAc (buffer A)/acetonitrile (ACN, buffer B) gradient (Time
0=10:90, 3=50:50, 5=50:50, 7=85:15, 10= off), followed by
7 min re-equilibration at 200 ml?min
21. The QTOF conditions
includedadryinggasflowrateof9 L?min
21withnebulizerpressure
of 25 psi and a 100V fragmentor. The first quad was set to isolate on
m/z values of 74.1 and 88.1. Collision energy was set to 15V and
product ions of IAA and IBA were targeted with positive mode
scans of m/z 50–200. The EEARSM peptide was analyzed by triple
quad LCMS using SMRM. 5 ml samples were resolved with the
Sequant ZIC-HILICcolumn, using a 10%ACN, 15 mMNH4OAc
(buffer A)/90% ACN, 15 mM NH4OAc (buffer B) gradient
(Time =0:100, 2=0:100, 10=50:50, 15=75:25, 18= off),
followed by 5 min re-equilibration at 250 ml?min
21. The EEARSM
722.3 -.464.4 transition state was produced with a 250 V
fragmentor and a 32V collision energy.
Data presentation and statistical analysis
All data is graphed as box plots, providing the mean, median,
and ranges of data, prior to data analysis. Whiskers span the
approximated 5–95% range (usually the minima and maxima) and
the box encompasses the 25–75% inner-quartile range, bisected by
the median line. The mean is represented by a dot. Body weights
and log10-transformed uterine weights [9,18] were analyzed by a
Student’s t-test or by one-way ANOVA and compared pairwise
using Dunnett’s (using PBS as the statistical control) or Tukey’s
HSD (all pairwise comparisons) test as indicated.
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